ICR

AI could be approximately twice as accurate as a biopsy at grading the aggressiveness of some sarcomas, according to research from The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research (ICR), London. Results from the study published in The Lancet Oncology suggest that a new AI algorithm could help tailor the treatment […]

A father from Cheshire has become one of the first patients in the world to take part in a study by researchers working at The Christie, Manchester, to measure the amount of oxygen in their tumour. Hypoxic cancers are more challenging to treat successfully, particularly when radiotherapy is given. By measuring the amount of oxygen […]

Men with prostate cancer are less likely to experience urinary and sexual side effects two years after treatment with an advanced type of radiotherapy than with surgery, according to researchers from The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research (ICR), London. The PACE-A study compares the long-term side effects of stereotactic […]

Magnetic Resonance Image Guided Radiotherapy (MRIgRT) course – The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust. September 26 – 27, 2022 Early bird registration fee before August 1, 2022 Click here for further information and registration. Or email caroline.saunders@icr.ac.uk. The MRIgRT course is an opportunity to broaden your understanding of the […]

Institute of Cancer Research scientists Professor Nick James and Professor Emma Hall have been recognised for their contributions to radiology and oncology by The Royal College of Radiologists. Professor James was awarded the RCR Gold Medal for his contribution to treatment of prostate and bladder cancer and to patient education. This is the highest honour […]

An optimised intensity modulated radiation therapy (IMRT) pioneered at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, has been shown to spare adverse life-long side effects in head and neck cancer patients following treatment. Initial results from the Dysphagia-Aspiration Related Structures (DARS) trial, funded by Cancer Research UK and the […]

Senior therapy radiographer Trina Herbert, lead research radiographer Dr Helen McNair and MR-linac radiographer Gillian Smith. The Royal Marsden and The Institute of Cancer Research, London, have delivered the first treatment in the UK using a MR-linac system.  The patient received radiotherapy treatment as part of the PRISM clinical trial, which is the first of […]

InHealth PETCT business director Mark Gleeson with trust consultant in nuclear medicine Professor Wim Oyen.  Courtesy of James Leask Frazer, Area1Photography. The Royal Marsden in Chelsea has been using an interim mobile PETCT solution provided by InHealth, to ensure an uninterrupted service while its own scanner was upgraded. A longstanding partner to the NHS, InHealth […]